Lauder Rodan & Fields Buy Adds Dermatological Brand To Skin Care Portfolio
This article was originally published in The Rose Sheet
Executive Summary
Estee Lauder is moving into the dermatological skin care category with the acquisition of Rodan & Fields, a product line developed by dermatologists and sold in selective high-end department stores
You may also be interested in...
Prostaglandin Analogues In Eyelash Cosmetics: Rodan & Fields To Settle Litigation For $38M
R&F will establish funds totaling $38m to put the kibosh on claims of fraud and unfair competition in US federal and state class actions, while maintaining it never intended its prostaglandin analogue-containing Lash Boost to impart drug-like structure and/or function effects on the human body. The settlement does not require R&F to stop selling Lash Boost or reformulate the product.
Estee Lauder suit
Former Rodan + Fields and Darphin exec Shashi Batra is instructed to comply with non-compete clause of his Estee Lauder contract under preliminary injunction issued by New York City federal court. Batra, who became NV Perricone Worldwide General Manager March 13, filed a lawsuit alleging the non-compete clause was illegal in California, where he was based during his time at Lauder. Cosmetics marketer will continue to pay Batra's salary for five months, during which time he is prohibited from working at Perricone. Duration was reduced from its original twelve months by the court. Batra was tapped general manager of R+F in 2004 and in 2005 added Darphin to his responsibilities (1"The Rose Sheet" May 9, 2005, In Brief). Lauder purchased French pharmacy company Darphin and dermatologist skin care firm R+F in 2003 (2"The Rose Sheet" Jan. 20, 2003, p. 4 and 3"The Rose Sheet" July 21, 2003, p. 9)...
Estee Lauder suit
Former Rodan + Fields and Darphin exec Shashi Batra is instructed to comply with non-compete clause of his Estee Lauder contract under preliminary injunction issued by New York City federal court. Batra, who became NV Perricone Worldwide General Manager March 13, filed a lawsuit alleging the non-compete clause was illegal in California, where he was based during his time at Lauder. Cosmetics marketer will continue to pay Batra's salary for five months, during which time he is prohibited from working at Perricone. Duration was reduced from its original twelve months by the court. Batra was tapped general manager of R+F in 2004 and in 2005 added Darphin to his responsibilities (1"The Rose Sheet" May 9, 2005, In Brief). Lauder purchased French pharmacy company Darphin and dermatologist skin care firm R+F in 2003 (2"The Rose Sheet" Jan. 20, 2003, p. 4 and 3"The Rose Sheet" July 21, 2003, p. 9)...